Cargando…
Inhibition of Allergic Response by Intranasal Selective NF-κB Decoy Oligodeoxynucleotides in a Murine Model of Allergic Rhinitis
PURPOSE: It remains unknown whether local inhibition of Nuclear factor-kappa B (NF-κB) could have therapeutic value in the treatment of allergic rhinitis (AR). This study aimed to evaluate the effect of selective NF-κB inhibition using NF-κB decoy oligodeoxynucleotides (ODNs) for the local treatment...
Autores principales: | Wee, Jee Hye, Zhang, Yu-Lian, Rhee, Chae-Seo, Kim, Dong-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102837/ https://www.ncbi.nlm.nih.gov/pubmed/27826963 http://dx.doi.org/10.4168/aair.2017.9.1.61 |
Ejemplares similares
-
Intranasal ciclesonide for allergic rhinitis
por: Williams, Ben, et al.
Publicado: (2008) -
Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011) -
Comparison of Intranasal Ciclesonide, Oral Levocetirizine, and Combination Treatment for Allergic Rhinitis
por: Kim, Chang-Hoon, et al.
Publicado: (2015) -
Role of Angiogenic Factors in Airway Remodeling in an Allergic Rhinitis Murine Model
por: Moon, Il Joon, et al.
Publicado: (2012) -
Modeling the therapeutic efficacy of NFκB synthetic decoy oligodeoxynucleotides (ODNs)
por: Wang, Zhipeng, et al.
Publicado: (2018)